Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT01132820 · COMPLETED

Trial details

NCT number: NCT01132820
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Recurrent Uterine Corpus Carcinoma

Start date: 2010-06-01
Primary completion: 2016-01-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.